Ep 36: Michael Craig & the CDC on AMR. Global antimicrobial consumption. Metronidazole resistance.
For this month of March, we bring you an interview with Mr. Michael Craig, director of the CDC's Antibiotic Resistance Coordination and Strategy, where we learn more about the role and work of public health agencies, how the CDC works in its strategy against antibiotic resistance, and the importance of prevention. In our news section, we present to you a recent publication on how the WHO antimicrobial resistance global action plan and the COVID-19 pandemic have impacted the global consumption of antimicrobials, and an article just published by one of our PhD students, investigating the mechanisms of metronidazole resistance in Giardia intestinalis. Hope you enjoy!
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
Relevant links:
- Antimicrobial/Antibiotic resistance website at the CDC (U.S.)
- Antimicrobial/Antibiotic resistance website at the ECDC (EU)
- TATFAR website.
Further Reading:
- Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19). First article covered in the news.
- Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics. Second article covered in the news.
If you have any comments and suggestions you can email us here, or tweet to us (@UAC_UU) using the hashtag #theAMRStudio.